Correlation Between Citigroup and Klaria Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citigroup and Klaria Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Klaria Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Klaria Pharma Holding, you can compare the effects of market volatilities on Citigroup and Klaria Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Klaria Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Klaria Pharma.

Diversification Opportunities for Citigroup and Klaria Pharma

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Citigroup and Klaria is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Klaria Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Klaria Pharma Holding and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Klaria Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Klaria Pharma Holding has no effect on the direction of Citigroup i.e., Citigroup and Klaria Pharma go up and down completely randomly.

Pair Corralation between Citigroup and Klaria Pharma

Taking into account the 90-day investment horizon Citigroup is expected to generate 0.29 times more return on investment than Klaria Pharma. However, Citigroup is 3.48 times less risky than Klaria Pharma. It trades about 0.16 of its potential returns per unit of risk. Klaria Pharma Holding is currently generating about -0.17 per unit of risk. If you would invest  6,083  in Citigroup on August 25, 2024 and sell it today you would earn a total of  901.00  from holding Citigroup or generate 14.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Citigroup  vs.  Klaria Pharma Holding

 Performance 
       Timeline  
Citigroup 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Citigroup exhibited solid returns over the last few months and may actually be approaching a breakup point.
Klaria Pharma Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Klaria Pharma Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Klaria Pharma is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Citigroup and Klaria Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citigroup and Klaria Pharma

The main advantage of trading using opposite Citigroup and Klaria Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Klaria Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klaria Pharma will offset losses from the drop in Klaria Pharma's long position.
The idea behind Citigroup and Klaria Pharma Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Correlations
Find global opportunities by holding instruments from different markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges